ARKG Holdings of Pfizer (PFE) - Updated Daily
Join Premium Plan
Key Statistics
Statistics
Clinical Trials (1205)
Institutional Ownership Trends
News That Matters
๐ต๐ผFound In | ๐ทLast Price |
---|---|
ARKG | $52.19 |
โ๏ธWeighting | ๐งขMarket Cap |
1.09% | $294.76b |
๐๐ฟโโ๏ธWeight Rank In ARKG | ๐งฎPrice to Sales |
33 | 3.63 |
๐๏ธโโ๏ธWeight Rank Across All Funds | โฉ๏ธDividend Yield |
77 | 3% |
๐ณARK Estimated Cost Average | ๐Country |
$47.57 | ๐บ๐ธUnited States |
๐ซARK Ownership Percent | |
0.01% |
Description | |
---|---|
Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. It strives to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, it collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, it has worked to make a difference for all who rely on it. It routinely posts information that may be important to investors on its website at www.Pfizer.com. | |
Website | |
www.pfizer.com |
Research Notes and Commentary for PFE
September 2, 2021
September 1-2: ARK Trades and Storylines
Trading Floor
August 24, 2021
August 23-24, 2021: ARK Trades and Storylines
Trading Floor
August 20, 2021
August 18-20, 2021: ARK Trades and Storylines
Trading Floor